Also, studies using antibodies against IL-17 and the IL-23 receptors have indicated a decrease in colon tumors in ETBF-colonized mice, confirming the involvement of IL-17 in ETBF-induced tumorigenesis [49]. The gene discussed is IL17A; the disease is colonic neoplasm.